Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management ; day:7 ; month:9 ; year:2023 ; pages:1-36
Journal of neurology ; (7.9.2023), 1-36
- Creator
-
Kümpfel, Tania
Giglhuber, Katrin
Aktas, Orhan
Ayzenberg, Ilya
Bellmann-Strobl, Judith
Häußler, Vivien
Havla, Joachim
Hellwig, Kerstin
Hümmert, Martin W.
Jarius, Sven
Kleiter, Ingo
Klotz, Luisa
Krumbholz, Markus
Paul, Friedemann
Ringelstein, Marius
Ruprecht, Klemens
Senel, Makbule
Stellmann, Jan-Patrick
Bergh, Florian Then
Trebst, Corinna
Tumani, Hayrettin
Warnke, Clemens
Wildemann, Brigitte
Berthele, Achim
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-023-11910-z
- URN
-
urn:nbn:de:101:1-2023123121090555887540
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kümpfel, Tania
- Giglhuber, Katrin
- Aktas, Orhan
- Ayzenberg, Ilya
- Bellmann-Strobl, Judith
- Häußler, Vivien
- Havla, Joachim
- Hellwig, Kerstin
- Hümmert, Martin W.
- Jarius, Sven
- Kleiter, Ingo
- Klotz, Luisa
- Krumbholz, Markus
- Paul, Friedemann
- Ringelstein, Marius
- Ruprecht, Klemens
- Senel, Makbule
- Stellmann, Jan-Patrick
- Bergh, Florian Then
- Trebst, Corinna
- Tumani, Hayrettin
- Warnke, Clemens
- Wildemann, Brigitte
- Berthele, Achim
- SpringerLink (Online service)
Other Objects (12)
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica
The Gut Microbiome in Neuromyelitis Optica
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica
The Gut Microbiome in Neuromyelitis Optica
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica